Biceps Tendon RuptureNCT02505347
Early Functional Return to Work Following Distal Biceps Repair
A study testing No splint and Splint in people with Biceps Tendon Rupture, run by University of Alberta at 1 site in Canada.
Trial summary
Distal biceps ruptures occur most commonly among young males in their third and fourth decade of life. These injuries are becoming more common, however, as the aging population is remaining active through sport or labour demands. Read more about this study
- Who is it for?
- Ages 18 to 65 years, men only
- Conditions the study is for
- Biceps Tendon Rupture
- What is being tested?
- No splint and Splint
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 104 participants
- Where
- 1 siteCanada
- Study dates
- Jul 2015to Sep 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- Men only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- male subjects between 18 and 65 years of age
- patient has had a DBTR amenable to surgical repair
- surgeon must be able to obtain a tension-free repair using an endobutton.
- participants must have been working prior to the injury
- patient must be expected to return to work post-injury
Who cannot join
- females
- outside of the specified age range
- patient with an identified congenital abnormality at the insertion of the distal biceps tendon
- those who have previously ruptured the tendon or those with tendon ruptures resulting from a multi-trauma
- patients with psychiatric illness, cognitive impairment, or health conditions that preclude informed consent
- patients with life expectancy of less than 2 years
Show all 9Show fewer
- patients who do not speak/read/understand English
- patients with no fixed address or contact information
- patients who are unwilling to complete follow-ups
Trial locations and contacts
1 site in 1 country.
About this study
Distal biceps ruptures occur most commonly among young males in their third and fourth decade of life. These injuries are becoming more common, however, as the aging population is remaining active through sport or labour demands. Distal biceps tears or ruptures follow a heavy eccentric load being placed on a shortened or flexed muscle, and often require surgical repair. Functionally, distal biceps injuries cause impairment as this portion of the muscle is largely responsible for supination and flexion at the elbow. Currently there is no consensus regarding post-operative immobilization protocols, and little evidence is available regarding timeframe for early return to functional activities. Existing evidence on functional outcomes post distal biceps tendon repair (DBTR) is of low quality with small sample sizes, and no known RCTs exist comparing early mobilization to immobilization on functional return. Reported timeframes for immobilization range from early controlled motion on day 1 post-operatively to complete immobilization for 6 weeks.
The primary study goal is to determine the effect of immobilization compared to unrestricted mobility post DBTR on early functional return to activities. It has been previously reported that those with DBTR related to a workers compensation injury returned to full duties in 3.95 months, while those with a non-workers compensation related injury returned to full work duties in 1.35 months. In Alberta, near 100 WCB claims were made for DBTR in both 2013 and 2014. Early mobilization of these repairs may allow an earlier return to modified and full work duties, thereby improving the functional quality of life of the individual as well as reducing the overall cost of disability payments.
This study will assess the 1) time to return to pre-injury work level and 2) time to return to modified duties among those who have no movement restriction post-repair and those who are splinted for 6 weeks. Re-rupture rates between groups will also be assessed as will strength, range of motion (ROM) and quality of life. These findings will assist in developing a standardized protocol for immobilization to optimize functional and clinical outcomes while expediting return to work.
Read the detailed description
Research Questions:
In patients who are immobilized for 6 weeks and those who are allowed unrestricted movement following DBTR, Are there differences during the first post-operative year in:
- Time to return to work (modified and pre-injury levels)?
- The proportion of subjects (if any) who re-rupture
- Strength (flexion, supination) of the elbow b. ROM (flexion, supination) of the elbow c. Self-reported functional quality of life d. Pain between groups
Research Hypotheses:
- A shorter time to return to work (modified and pre-injury levels) will be identified for the unrestricted movement group compared to the immobilized group.
- Less than 2% of patients in either group will re-rupture during the first post-operative year.
- Patients in the unrestricted movement group will have greater early improvements in a) strength; b) ROM; c) functional quality of life scores; and d) pain in the first 3-6 postoperative months compared to those in the immobilized group.
Theoretical significance and practical importance Currently there is no consensus regarding post-operative immobilization protocols, and little evidence is available regarding timeframe for early return to functional activities following DBTR. Existing evidence on functional outcomes post DBTR is of low quality with small sample sizes, and no known RCTs exist comparing early mobilization to immobilization on functional return. Reported timeframes for immobilization range from early controlled motion on day 1 post-operatively to complete immobilization for 6 weeks.
The primary study goal is to determine the effect of immobilization for 6 weeks post-operatively compared to unrestricted mobility post DBTR on early functional return to activities. It has been previously reported that those with DBTR related to a workers compensation injury returned to full duties in 3.95 months, while those with a non-workers compensation related injury returned to full work duties in 1.35 months. In Alberta, near 100 WCB claims were made annually for DBTR in both 2013 and 2014. Early mobilization of these repairs may allow an earlier return to modified and full work duties, thereby improving the functional quality of life of the individual as well as reducing the overall cost of disability payments.
Research plan and methodology Design/Setting: This study is a parallel randomized control trial with computer generated randomization blocks stratified by surgeon. Patient enrollment and follow-up will occur primarily at Sturgeon Community Hospital (SCH).
Sample Size To ensure that the study is properly powered to detect a difference between groups with a power = 0.90, α = 0.05, µ1 = 14 (unrestricted mobility), µ2 = 21 (immobilized), δ = 10, a total of 88 participants is required (44 to each group). To allow for attrition of sample size in the first year, we will enroll up to 100 subjects (50 in each study arm).
This calculation is based on a conservative estimate of a 1 week difference in return to work between groups. If the group differences is greater than 1 week we will remain well-powered. If the group difference is less than 1 week, this is likely not a clinically important difference between groups.
This sample size of 100 should also be sufficient to allow for further sub-analyses between participants who are WCB claimants and those who are not and is adequately powered to compare the secondary and tertiary outcomes between groups, with the exception of re-ruptures, which is expected to be very low in both groups.
Screening and Enrollment Patients will be screened for study eligibility at their initial preoperative clinic visit by the attending surgeon and research coordinator. The research coordinator will track reasons for exclusion, either by patient refusal or surgeon exclusion based on patient characteristics. Those who consent will sign and complete an informed consent form and undergo a baseline evaluation.
Baseline Evaluation: Consented subjects will undergo a pre-operative assessment by a study therapist who is independent of their clinical care. The assessment will consist of 1) baseline demographics form (age, mechanism of injury, past and current medical status, work and activity demands; dominant hand), 2) work-related questions (i.e. occupation, employment status, type of work performed) 3) the Quick Disabilities of the Arm, Shoulder, and Hand questionnaire (Q-DASH), 4) visual analogue scale (VAS) for pain at rest and with activity 5) bilateral elbow ROM in the planes of supination and flexion, 6) bilateral elbow strength for flexion and supination using a handheld dynamometer (microFET3, Hoggan Health Industries Inc., West Jordan, UT), and 7) an ultrasound or MRI to confirm the diagnosis. Imaging at this pre-operative stage is standard of care, and not dependent on study involvement. All data will be collected using standardized forms and entered into a password-protected database.
Intervention
Based upon the surgeons' ability to perform a tension free repair, subjects will be randomized following surgery to either:
- immobilized for 6 weeks postoperative or
- unrestricted mobility Those in the immobilized group will be splinted as per current care for 6 weeks, and will remove the splint only for personal care or active-assisted ROM and gentle stretching exercises, as prescribed by an occupational/physical therapist.
Those with unrestricted mobility will be able to move the joint as tolerated post-operatively, but will avoid heavy lifting (>5 pounds) in the first six postoperative weeks.
Those patients who consent, but are excluded at time of surgery will be noted to determine the proportion of patients who are able to participate in an early mobilization regimen. Reasons for exclusion will be recorded.
Rehabilitation Each patient will be referred for a course of physiotherapy post-operatively. Although principles of tissue healing will be followed for both groups, patients in the unrestricted mobility group are likely to start progressive resisted activities by 6-8 weeks post-operatively while the immobilized group will likely not start progressive resisted activities until 8-10 weeks post-operatively. Time (days) of splinting in the immobilized group will be recorded as the time from when the splint was applied post-operatively to the date the splint was fully discontinued. Start and end dates for physiotherapy will be recorded as will the timing of commencing resisted activities.
Follow-up Evaluation Participants will be reassessed by the research coordinator and surgeon at their usual clinic follow-ups at 6 weeks, and 3 and 6 months. Participants will be reassessed by the research coordinator only at 12 months post-operatively.
At each visit outcomes to be recorded will include: current working status (not yet working, modified, full duties) and date of return to any work, ROM measurements, Q-DASH questionnaire, and VAS pain scale. Any complications related to their injury or causing a delay in return to work will also be noted.
Commencing at the 3 month visit and continuing for all subsequent visits, strength will also be assessed using a myometer. Start and end dates of physiotherapy treatment will be recorded to compare the rehabilitation course between groups. Ultrasound imaging will be performed at 12 months, or if there is any history of re-injury to confirm the integrity of the repair.
Analysis We will be using quantitative analytical methods. Descriptive statistics (frequencies, proportions, means and variation) will be determined for all variables.
For the primary outcome (time [days] for return to modified duties) we will use an unpaired t-test to assess for differences between both groups. T-tests will also be used to analyze secondary outcomes (time to return to pre-injury level of work, re-rupture rates, and Q-DASH scores), and time (days) of splinting in the immobilized group will be reported descriptively (mean). Tertiary outcomes (strength, ROM, Q-DASH) will be analyzed using a two-way repeated measure ANOVA to examine the trajectory of recovery between groups.
A further sub-analysis will be performed to assess primary and secondary outcomes between immobilized and unrestricted mobility groups for those who are identified as work related injury compared to non-work related injury using an analysis of covariance (ANCOVA).
All analyses will be two-tailed with a level of significance of α=0.05.
- Conditions
- Biceps Tendon Rupture
- Being tested
- No splint, Splint
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
No splintOther
Can move arm as tolerated with no restrictions on mobility
SplintDevice
Wear splint for 6 weeks, only to remove for rehab and personal care
| Study group | Role | What they receive |
|---|---|---|
| No splint | Experimental | will be able to move the arm as tolerated following surgery. Receives: Other: No splint |
| Splint | Active comparator | will receive a splint following surgery for 6 weeks. Receives: Device: Splint |
What is being measured
The primary outcome is the main question the study is designed to answer.
Time (days) to return to work on modified duties
Self reported
Measured: 1 year
Secondary outcomes (2)
Time (days) to return to pre-injury level of work
Self reported
Measured: 12 months
Re-rupture rate
Measured by ultrasound at final visit
Measured: 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Jul 2015 (estimated)
- Study startJul 2015
- Primary completionApr 2019
- Study completionSep 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Biceps Tendon RuptureStudies of the same condition, open and under way.
- More trials run by University of AlbertaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 104 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Alberta
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Lauren Beaupre, PT, PhD, Principal investigator, University of Alberta
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02505347
- Sponsor's protocol ID
- Pro00057067
- Status last verified
- Sep 2021
- First submitted
- 30 Jun 2015
- Last updated
- 22 Sep 2022
- Results posted
- No
- Data monitoring committee
- No
Publications
Bergman JW, Silveira A, Chan R, Lapner M, Hildebrand KA, Le ILD, Sheps DM, Beaupre LA, Lalani A. Is Immobilization Necessary for Early Return to Work Following Distal Biceps Repair Using a Cortical Button Technique?: A Randomized Controlled Trial. J Bone Joint Surg Am. 2021 Oct 6;103(19):1763-1771. doi: 10.2106/JBJS.20.02047.
PubMed 34166263
Study at a glance
From the registry record, last updated by the sponsor on 22 Sep 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Early Functional Return to Work Following Distal Biceps Repair
- ClinicalTrials.gov ID
- NCT02505347
- Acronym / sponsor ID
- Pro00057067
- Conditions
- Biceps Tendon Rupture
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 104 participants (actual)
- Lead sponsor
- University of AlbertaUniversity, hospital or other
- Study start
- Jul 2015 (actual)
- Primary completion
- Apr 2019 (actual)
- Study completion
- Sep 2019 (actual)
- First posted
- 22 Jul 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Distal biceps ruptures occur most commonly among young males in their third and fourth decade of life. These injuries are becoming more common, however, as the aging population is remaining active through sport or labour demands. Distal biceps tears or ruptures follow a heavy eccentric load being placed on a shortened or flexed muscle, and often require surgical repair. Functionally, distal biceps injuries cause impairment as this portion of the muscle is largely responsible for supination and flexion at the elbow. Currently there is no consensus regarding post-operative immobilization protocols, and little evidence is available regarding timeframe for early return to functional activities. Existing evidence on functional outcomes post distal biceps tendon repair (DBTR) is of low quality with small sample sizes, and no known RCTs exist comparing early mobilization to immobilization on functional return. Reported timeframes for immobilization range from early controlled motion on day 1 post-operatively to complete immobilization for 6 weeks.
The primary study goal is to determine the effect of immobilization compared to unrestricted mobility post DBTR on early functional return to activities. It has been previously reported that those with DBTR related to a workers compensation injury returned to full duties in 3.95 months, while those with a non-workers compensation related injury returned to full work duties in 1.35 months. In Alberta, near 100 WCB claims were made for DBTR in both 2013 and 2014. Early mobilization of these repairs may allow an earlier return to modified and full work duties, thereby improving the functional quality of life of the individual as well as reducing the overall cost of disability payments.
This study will assess the 1) time to return to pre-injury work level and 2) time to return to modified duties among those who have no movement restriction post-repair and those who are splinted for 6 weeks. Re-rupture rates between groups will also be assessed as will strength, range of motion (ROM) and quality of life. These findings will assist in developing a standardized protocol for immobilization to optimize functional and clinical outcomes while expediting return to work.
Detailed description
Research Questions:
In patients who are immobilized for 6 weeks and those who are allowed unrestricted movement following DBTR, Are there differences during the first post-operative year in:
- Time to return to work (modified and pre-injury levels)?
- The proportion of subjects (if any) who re-rupture
- Strength (flexion, supination) of the elbow b. ROM (flexion, supination) of the elbow c. Self-reported functional quality of life d. Pain between groups
Research Hypotheses:
- A shorter time to return to work (modified and pre-injury levels) will be identified for the unrestricted movement group compared to the immobilized group.
- Less than 2% of patients in either group will re-rupture during the first post-operative year.
- Patients in the unrestricted movement group will have greater early improvements in a) strength; b) ROM; c) functional quality of life scores; and d) pain in the first 3-6 postoperative months compared to those in the immobilized group.
Theoretical significance and practical importance Currently there is no consensus regarding post-operative immobilization protocols, and little evidence is available regarding timeframe for early return to functional activities following DBTR. Existing evidence on functional outcomes post DBTR is of low quality with small sample sizes, and no known RCTs exist comparing early mobilization to immobilization on functional return. Reported timeframes for immobilization range from early controlled motion on day 1 post-operatively to complete immobilization for 6 weeks.
The primary study goal is to determine the effect of immobilization for 6 weeks post-operatively compared to unrestricted mobility post DBTR on early functional return to activities. It has been previously reported that those with DBTR related to a workers compensation injury returned to full duties in 3.95 months, while those with a non-workers compensation related injury returned to full work duties in 1.35 months. In Alberta, near 100 WCB claims were made annually for DBTR in both 2013 and 2014. Early mobilization of these repairs may allow an earlier return to modified and full work duties, thereby improving the functional quality of life of the individual as well as reducing the overall cost of disability payments.
Research plan and methodology Design/Setting: This study is a parallel randomized control trial with computer generated randomization blocks stratified by surgeon. Patient enrollment and follow-up will occur primarily at Sturgeon Community Hospital (SCH).
Sample Size To ensure that the study is properly powered to detect a difference between groups with a power = 0.90, α = 0.05, µ1 = 14 (unrestricted mobility), µ2 = 21 (immobilized), δ = 10, a total of 88 participants is required (44 to each group). To allow for attrition of sample size in the first year, we will enroll up to 100 subjects (50 in each study arm).
This calculation is based on a conservative estimate of a 1 week difference in return to work between groups. If the group differences is greater than 1 week we will remain well-powered. If the group difference is less than 1 week, this is likely not a clinically important difference between groups.
This sample size of 100 should also be sufficient to allow for further sub-analyses between participants who are WCB claimants and those who are not and is adequately powered to compare the secondary and tertiary outcomes between groups, with the exception of re-ruptures, which is expected to be very low in both groups.
Screening and Enrollment Patients will be screened for study eligibility at their initial preoperative clinic visit by the attending surgeon and research coordinator. The research coordinator will track reasons for exclusion, either by patient refusal or surgeon exclusion based on patient characteristics. Those who consent will sign and complete an informed consent form and undergo a baseline evaluation.
Baseline Evaluation: Consented subjects will undergo a pre-operative assessment by a study therapist who is independent of their clinical care. The assessment will consist of 1) baseline demographics form (age, mechanism of injury, past and current medical status, work and activity demands; dominant hand), 2) work-related questions (i.e. occupation, employment status, type of work performed) 3) the Quick Disabilities of the Arm, Shoulder, and Hand questionnaire (Q-DASH), 4) visual analogue scale (VAS) for pain at rest and with activity 5) bilateral elbow ROM in the planes of supination and flexion, 6) bilateral elbow strength for flexion and supination using a handheld dynamometer (microFET3, Hoggan Health Industries Inc., West Jordan, UT), and 7) an ultrasound or MRI to confirm the diagnosis. Imaging at this pre-operative stage is standard of care, and not dependent on study involvement. All data will be collected using standardized forms and entered into a password-protected database.
Intervention
Based upon the surgeons' ability to perform a tension free repair, subjects will be randomized following surgery to either:
- immobilized for 6 weeks postoperative or
- unrestricted mobility Those in the immobilized group will be splinted as per current care for 6 weeks, and will remove the splint only for personal care or active-assisted ROM and gentle stretching exercises, as prescribed by an occupational/physical therapist.
Those with unrestricted mobility will be able to move the joint as tolerated post-operatively, but will avoid heavy lifting (>5 pounds) in the first six postoperative weeks.
Those patients who consent, but are excluded at time of surgery will be noted to determine the proportion of patients who are able to participate in an early mobilization regimen. Reasons for exclusion will be recorded.
Rehabilitation Each patient will be referred for a course of physiotherapy post-operatively. Although principles of tissue healing will be followed for both groups, patients in the unrestricted mobility group are likely to start progressive resisted activities by 6-8 weeks post-operatively while the immobilized group will likely not start progressive resisted activities until 8-10 weeks post-operatively. Time (days) of splinting in the immobilized group will be recorded as the time from when the splint was applied post-operatively to the date the splint was fully discontinued. Start and end dates for physiotherapy will be recorded as will the timing of commencing resisted activities.
Follow-up Evaluation Participants will be reassessed by the research coordinator and surgeon at their usual clinic follow-ups at 6 weeks, and 3 and 6 months. Participants will be reassessed by the research coordinator only at 12 months post-operatively.
At each visit outcomes to be recorded will include: current working status (not yet working, modified, full duties) and date of return to any work, ROM measurements, Q-DASH questionnaire, and VAS pain scale. Any complications related to their injury or causing a delay in return to work will also be noted.
Commencing at the 3 month visit and continuing for all subsequent visits, strength will also be assessed using a myometer. Start and end dates of physiotherapy treatment will be recorded to compare the rehabilitation course between groups. Ultrasound imaging will be performed at 12 months, or if there is any history of re-injury to confirm the integrity of the repair.
Analysis We will be using quantitative analytical methods. Descriptive statistics (frequencies, proportions, means and variation) will be determined for all variables.
For the primary outcome (time [days] for return to modified duties) we will use an unpaired t-test to assess for differences between both groups. T-tests will also be used to analyze secondary outcomes (time to return to pre-injury level of work, re-rupture rates, and Q-DASH scores), and time (days) of splinting in the immobilized group will be reported descriptively (mean). Tertiary outcomes (strength, ROM, Q-DASH) will be analyzed using a two-way repeated measure ANOVA to examine the trajectory of recovery between groups.
A further sub-analysis will be performed to assess primary and secondary outcomes between immobilized and unrestricted mobility groups for those who are identified as work related injury compared to non-work related injury using an analysis of covariance (ANCOVA).
All analyses will be two-tailed with a level of significance of α=0.05.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| No splint | Experimental | Other: No splintwill be able to move the arm as tolerated following surgery. |
| Splint | Active comparator | Device: Splintwill receive a splint following surgery for 6 weeks. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- Male only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- male subjects between 18 and 65 years of age
- patient has had a DBTR amenable to surgical repair
- surgeon must be able to obtain a tension-free repair using an endobutton.
- participants must have been working prior to the injury
- patient must be expected to return to work post-injury
Key exclusion criteria (9 listed)
- females
- outside of the specified age range
- patient with an identified congenital abnormality at the insertion of the distal biceps tendon
- those who have previously ruptured the tendon or those with tendon ruptures resulting from a multi-trauma
- patients with psychiatric illness, cognitive impairment, or health conditions that preclude informed consent
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| No splintCan move arm as tolerated with no restrictions on mobility | Other | No splint |
| SplintWear splint for 6 weeks, only to remove for rehab and personal care | Device | Splint |
Primary outcome
Time (days) to return to work on modified duties
Time frame: 1 year
Self reported
2 secondary outcomes
Time (days) to return to pre-injury level of work
Time frame: 12 months
Re-rupture rate
Time frame: 12 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Sep 2022.
- Background: PubMed 34166263Bergman JW, Silveira A, Chan R, Lapner M, Hildebrand KA, Le ILD, Sheps DM, Beaupre LA, Lalani A. Is Immobilization Necessary for Early Return to Work Following Distal Biceps Repair Using a Cortical Button Technique?: A Randomized Controlled Trial. J Bone Joint Surg Am. 2021 Oct 6;103(19):1763-1771. doi: 10.2106/JBJS.20.02047.
- Study Video SummaryLink provided by the sponsor.
- OrthoEvidenceLink provided by the sponsor.
Related trials for Biceps Tendon Rupture
Recruiting
Arthroscopic Rotator Cuff Repair With Long Head of Biceps Transposition and Acellular Dermal Matrix Augmentation for Large to Massive Incompletely Repairable Rotator Cuff Tears
Rotator Cuff Tears, Rotator Cuff Injuries
Not yet recruiting
Percutaneous Tenotomy Versus Radiofrequency Ablation for Rotator Cuff Tear - Related Pain.
Rotator Cuff Tear, Pain Management
Recruiting
Biceps Lasso Loop and Self- Locking Tenodesis Alongside Repair of Rotator Cuff Tears: Randomised Controlled Trial Study Protocol (BLAST 1)
Rotator Cuff Injury
Recruiting
Electroacupuncture and Cupping for Shoulder Tendinitis
Shoulder Tendinopathy, Shoulder Tendinitis
Not yet recruiting
Clinical Trial to Compare Clinical and Functional Results of the Augmentation of Supraspinatus Tears With the Long Head of the Biceps Brachii Tendon
Rotator Cuff Tear Surgical Repair
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Lauren Beaupre, PT, PhD principal investigator
University of Alberta
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing No splint and Splint in people with Biceps Tendon Rupture, run by University of Alberta at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 22 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Time (days) to return to work on modified duties (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02505347, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Sep 2022.